Hopeful Please rethink the Mayo MRI, they might do a plain one, but as of contrast please know, it has been causing issues with some patients despite having good kidneys: I had 6 for "brain issues when I had LYME!!! and one for pancreas, after being given so many for brain I developed severe gastro symptoms, malabsorbption, dropped to 92 lbs and also became Hyoperthryoid then thyroid cancer which they took out at the same time as the styloid just 3 months ago tray!!
DR Cognetti is well aware of the issues I brought up to him about MRI contrast but he is at JEfferosn in Philly. IF you need particular articles I can hook you up. iCat
PS: I don't want anyone developing a Non-nephrogenic case of systemic fibrosis if I can help it, I will ge this diagnose done and for all, I figure sepnign so much time on NET I am bound to ! ; > )
AUNT MINNIE & GE & $5 Million verdict
Study links Gadolinium MR contrast to brain abnormalities
By Wayne Forrest, AuntMinnie.com staff writer
Radiology. 2014 Mar;270(3):834-41. doi: 10.1148/radiol.13131669. Epub 2013 Dec 7.
High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.
Kanda T1, Ishii K, Kawaguchi H, Kitajima K, Takenaka D.
Specter of MRI Disease Haunts General Electric
GE Failed to Adequately Warn about Dangers of its MRI Dye, Jury Finds
by Jeff Gerth
ProPublica, March 22, 2013, 2:41 p.m.
$5 Million Verdict In The First Gadolinium Injury Trial
Tags: claims, Gadolinium Verdict, GE Healthcare, lawsuit, lawyer, litigation, Product Liability
A federal jury in Ohio has awarded $5 million in the first case to go to trial in the multi district litigation involving patients who claim injury from the body scan contrast agent gadolinium. The jury found that GE Healthcare failed to provide adequate warnings of the health risk posed to those with impaired kidney function from Omniscan. As we have reported, the GE product is a gadolinium-based contrast dye used in MRIs and other imaging scans. The plaintiff in the case, Paul Decker, contracted a debilitating skin disease — nephrogenic systemic fibrosis (NSF) — as a result of being injected with Omniscan for a magnetic resonance angiogram in 2005. At the time, Decker was also undergoing dialysis for end-stage kidney disease.